Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
6.26
-0.47 (-6.98%)
At close: Apr 1, 2025, 4:00 PM
6.30
+0.04 (0.64%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Immunome Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
54466345727157102
Upgrade
Market Cap Growth
44.98%44.98%1605.70%-82.91%53.68%-
Upgrade
Enterprise Value
332425367-0101151
Upgrade
Last Close Price
6.2610.6210.702.2112.969.68
Upgrade
PS Ratio
40.6073.3232.62---
Upgrade
PB Ratio
2.233.663.811.613.262.47
Upgrade
P/TBV Ratio
3.663.663.811.613.262.47
Upgrade
EV/Sales Ratio
36.7047.0626.18---
Upgrade
Debt / Equity Ratio
0.030.030.010.02-0.02
Upgrade
Asset Turnover
0.050.050.16---
Upgrade
Quick Ratio
4.004.006.332.895.5013.37
Upgrade
Current Ratio
4.084.086.633.095.8214.12
Upgrade
Return on Equity (ROE)
-194.63%-194.63%-156.45%-113.81%-55.20%-79.97%
Upgrade
Return on Assets (ROA)
-49.34%-49.34%-20.81%-56.27%-30.75%-30.91%
Upgrade
Return on Capital (ROIC)
-62.38%-62.38%-25.93%-70.82%-34.95%-33.47%
Upgrade
Earnings Yield
-53.82%-44.20%-23.36%-137.65%-15.76%-17.48%
Upgrade
FCF Yield
-30.19%-24.79%-1.84%-107.96%-11.67%-12.46%
Upgrade
Buyback Yield / Dilution
-195.51%-195.51%-63.64%-5.10%-240.41%-209.85%
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q